» Articles » PMID: 30448114

Relationship Between Left Ventricular Ejection Fraction and Mortality in Asymptomatic and Minimally Symptomatic Patients With Severe Aortic Stenosis

Abstract

Objectives: This study sought to determine the best left ventricular ejection fraction (LVEF) cutoff value to predict long-term mortality in patients with asymptomatic or minimally symptomatic severe aortic stenosis (AS) and LVEF ≥50% under conservative management and after surgical correction of AS.

Background: Aortic valve replacement (AVR) is a Class I indication in asymptomatic patients with severe AS and LVEF <50%. However, this is an uncommon situation in asymptomatic severe AS (<1% of patients), usually occurring late in the course of the disease. No data are available concerning the prognostic value of LVEF in asymptomatic or minimally symptomatic AS patients with preserved LVEF (≥50%) in order to identify a LVEF threshold value associated with increased mortality.

Methods: This analysis included 1,678 patients with preserved LVEF and no or minimal symptoms, with a diagnosis of severe AS. The population was divided into 3 groups: LVEF <55%, LVEF 55% to 59%, and LVEF ≥60%.

Results: Five-year survival rate was 72 ± 2% for patients with LVEF ≥60%, 74 ± 2% for patients with LVEF between 55% and 59%, and 59 ± 4% for patients with LVEF <55% (p < 0.001). Under initially conservative or initially surgical management (surgery within 3 months after baseline echocardiography), patients with LVEF <55% displayed significant excess mortality compared to patients with LVEF≥ 60% (adjusted hazard ratio [HR]: 2.44 [95% confidence interval: 1.51 to 3.94]; p < 0.001 and 2.51 [95% confidence interval: 1.58 to 4.00]; p < 0.001, respectively), whereas patients with LVEF between 55% and 59% had comparable prognosis to those with LVEF ≥60% (p = 0.53 and p = 0.36, respectively). In patients with LVEF <55%, initial conservative management was associated with increased mortality compared to initial surgical management, even after covariate adjustment (adjusted hazard ratio [HR]: 2.70 [95% confidence interval: 1.98 to 3.67]; p < 0.001).

Conclusions: In patients with severe AS, preserved LVEF and no or minimal symptoms at the time of diagnosis, LVEF <55% is a marker of poor outcome, with medical or surgical management suggesting that these patients should be considered for surgery before this stage.

Citing Articles

Asian Pacific Society of Cardiology Position Statement on the Use of Transcatheter Aortic Valve Implantation in the Management of Aortic Stenosis.

Yap J, Hayashida K, Lee M, Stub D, Hon J, Ho K JACC Asia. 2025; 4(12):885-897.

PMID: 39802986 PMC: 11712005. DOI: 10.1016/j.jacasi.2024.10.001.


Quantification of Replacement Fibrosis in Aortic Stenosis: A Narrative Review on the Utility of Cardiovascular Magnetic Resonance Imaging.

Rajah M, Doubell A, Herbst P Diagnostics (Basel). 2024; 14(21).

PMID: 39518402 PMC: 11544846. DOI: 10.3390/diagnostics14212435.


The Relative Apical Sparing Strain Pattern in Severe Aortic Valve Stenosis: A Marker of Adverse Cardiac Remodeling.

Ramanauskaite D, Balciunaite G, Palionis D, Besusparis J, Zurauskas E, Janusauskas V J Pers Med. 2024; 14(7).

PMID: 39063961 PMC: 11277935. DOI: 10.3390/jpm14070707.


Cardiac Damage Staging Predicts Outcomes in Aortic Valve Stenosis After Aortic Valve Replacement: Meta-Analysis.

Abdelfattah O, Jacquemyn X, Sa M, Jneid H, Sultan I, Cohen D JACC Adv. 2024; 3(5):100959.

PMID: 38939639 PMC: 11198616. DOI: 10.1016/j.jacadv.2024.100959.


Quantifying the Survival Loss Linked to Late Therapeutic Indication in High-Gradient Severe Aortic Stenosis.

De Azevedo D, Boute M, Tribouilloy C, Marechaux S, Pouleur A, Bohbot Y JACC Adv. 2024; 3(3):100830.

PMID: 38938822 PMC: 11198331. DOI: 10.1016/j.jacadv.2024.100830.